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Abstract
Tomographic imaging of a glioma tumor with endogenous fluorescence is demonstrated using a non-
contact single photon counting fan-beam acquisition system interfaced with microCT imaging. The
fluorescence from protoporphyrin IX was found to be detectable, and allowed imaging of the tumor
from within the cranium, even though the tumor presence was not visible in the microCT image. The
combination of single photon counting detection and normalized fluorescence to transmission
detection at each channel allowed robust imaging of the signal. This demonstrated use of endogenous
fluorescence stimulation from aminolevulinic acid, provides the first in vivo demonstration of deep
tissue tomographic imaging with protoporphyrin IX.
Fluorescence tomography provides a tool for pre-clinical molecular contrast agent assessment
in oncology(1-4). Systems have advanced in complexity to where non-contact imaging(5),
automated boundary recovery (6) and sophisticated internal tissue shapes can be included in
the recovered images. The translation of this work to humans will require molecular contrast
agents which are amenable to regulatory approval, and maintain tumor specificity in humans,
where often non-specific uptake of molecular imaging agents can decrease their utility. In this
study, a new fluorescence tomography system coupled to microCT (7) was used to illustrate
diagnostic detection of orthotopic glioma tumors that were not apparent in the microCT images,
using endogenous fluorescent contrast from protoporphyrin IX (PpIX).
Glioma tumors provide significant endogenous fluorescence from PpIX (8-11) and this is
enhanced when the subject imaged has been administered aminolevulinic acid. The
endogenous production process if PpIX is known to stem from the administered ALA
bypassing the regulatory inhibition of ALA synthase, allowing the heme synthesis pathway to
proceed uninhibited. Since there is limited supply of iron in the body, this process produces
overabundance of PpIX rather than heme, and many tumors have been shown to have high
yields of PpIX. Clinical trials with PpIX fluorescence guided resection of tumors has shown
significant promise(12), and yet deep tissue imaging with PpIX fluorescence has not been
exploited in clinical use. Early studies have shown that detection of these tumors with PpIX is
feasible (13,14), but no tomographic imaging has been used. This limitation in development
has largely been caused by problems in wavelength filtering and low signal intensity, as well
as background fluorescence from the skin limiting sensitivity to deeper structures. In the system
developed and used here, this feasibility is demonstrated by imaging a human xenograft glioma
model.
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To solve the sensitivity problem, and study the ability to diagnostically image PpIX in vivo,
time-correlated single photon counting was used in the fluorescence tomography system which
provides maximum sensitivity. Figure 1 (a) shows the system designed to match up with a
microCT, allowing both x-ray structural and optical functional imaging sequentially. Lens
coupled detection of signals are acquired from the mouse using 5 time-resolved photomultiplier
tubes (H7422P-50, Hamamatsu, Japan) with single photon counting electronics (SPC-134
modules, Becker and Hickl GmbH, Germany). The system has fan-beam transmission
geometry similar to a standard CT scanner, with single source delivery of a 1 mW pulsed diode
laser light at 635 nm, collimated to a 1 mm effective area on the animal. The 5 detection lenses
were arranged in an arc, each with 22.5° angular separation, centered directly on the opposite
side of the animal with long working distance pickup (7), allowing non-contact measurement
of the diffuse light through the animal. The diffuse intensity signals collected at each of the 5
channels were then translated via 400 μm fibers, and split using beamsplitters to be directed
toward the fluorescence (95%) and transmission (5%) channel detectors. A 650 long-pass filter
was used in the fluorescence channels to isolate the signal, and in the transmitted intensity
signals a neutral density filter (2 OD) was used to attenuate the signals. This latter filtering was
necessary to ensure the fluorescence and transmission intensity signals fell within the same
dynamic range, allowing a single 1 second acquisition for each detector. Scans were then
performed by rotating the fan-beam around the specimen to 32 locations. A GE eXplore Locus
SP scanner (GE Healthcare, London ON Canada) that incorporated a detector with 94 micron
pixel resolution, a 80kV peak voltage, and a tube current of 450 μAs, was used in acquiring
the microCT data, as displayed in Figure 3. In this example, since soft tissue was being imaged,
the CT data was largely used to image the exterior of the animal, although in future studies it
could be used to isolate the cranium region as well.
Calibration of the fluorescence tomography system was carried out with standard tissue-
simulating epoxy resin phantoms with tissue-like scatter and absorption coefficients. The
details of the calibration procedure have been reported previously (7,15-17) and a single
phantom is shown here to illustrate the type of data, as shown in Figure 1(b). The phantom
contained an 8mm liquid inclusion filled with 1μg/ml PpIX. This concentration is similar to
that seen in malignant gliomas (12-14). Experimental data sets were then calibrated into the
fluorescence to transmission signal ratio at each detection location and then the signal was
scaled such that the average ratio matched that of the model (16,18). In Figure 1 (c), the
calibrated dataset used to generate this image is shown along with the reconstructed fit,
illustrating convergence of this dataset with NIRFAST finite-element-based non-linear
reconstruction (17,19). The system noise was determined at SNR of 1.1% in the raw
fluorescence-to-transmission data, as assessed by repeated samplings of a stable signal. This
level is acceptable for reconstruction of the fluorescence yield, and consistent with levels seen
in previous diffuse tomography systems. The concentration of PpIX in the phantom was
increased over ranges expected in tissue, and the images were reconstructed. The value in the
region of interest was extracted and plotted in Figure 2.
The animal model was the U251 xenograft glioma line, grown in the laboratory for ongoing
detection studies and published extensively (13,14) and is known to have high PpIX levels.
The experimental plan was approved by the Institutional Animal Care and Use Committee.
Briefly 106 cells were stereotactically implanted into the brain in 10 μL of PBS through a
Hamilton syringe, through a 1 mm hole in the skull. Tumors were implanted 2mm deep into
the brain with injection over 5 minutes. The tumor was incubated for 14 days and imaged in
vivo with contrast magnetic resonance to assess size and location. Figure 3(a) shows a
gadolinium-enhanced T1 weighted image of the tumor. A microCT dataset was then acquired
and an exposure time of 100 ms was used, with 3 repeated measurements at each of the 400
gantry angles, for a total acquisition time of 11 minutes. The mouse bed to hold the animal was
the original microCT carbon fiber bed supplied by GE, with slots cut to allow optical
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measurement laterally across the cranium. After CT imaging, the animal and bed were
positioned in the fluorescence tomography system and a pre-ALA-injection dataset was
acquired with 64 angles using integration time of 4 seconds per angle, with a 10 minute total
acquisition. Following administration of ALA and incubation over 1 hr, the animal was re-
imaged using the fluorescence scanner, and a post contrast dataset was generated. The external
boundary representing the cranium in the 2-D region of interest was then segmented and used
to create a finite element mesh (20) for fluorescence tomography reconstruction. The contour
information from the microCT allowed calculation of source and detector locations in an
automated fashion.
The peak Q-band excitation for PpIX is known to be at 635 nm wavelength excitation with a
molar absorption coefficient near 104 M−1 cm−1, which is why the system designed here used
this laser for excitation. The peak of the emission is near 640 nm, which would be challenging
to detect with 635 nm excitation because of the problems in filtering. However it has a long
emission tail with a second peak out near 700 nm, allowing effective fluorescence detection
with the 650 nm long pass filters designed into the system. The fluorescence quantum yield of
this compound is estimated to be near 0.5% (16). The fluorescence to transmission ratio data
was calibrated as in the phantom study and reconstructed to create the image in Figure 3 (b).
This was then superimposed on the microCT image, as shown in Figure 3 (c), to create a hybrid
structural functional image of the endogenous fluorescence contrast. The microCT image did
not show any evidence of the tumor, and prior studies with injected contrast did not show any
promise of visualizing this intracranial tumor, due to the inherent soft tissue contrast limitations
of microCT imaging. Recovery of the spatial distribution of fluorescence yield was robust
however, and indicates an effective Pp-IX concentration near 10 μg/ml. This value is based
upon the phantom calibration curve, although exact quantitative recovery of tomographic
images must be interpreted carefully with validation by similar sized objects in similar positions
to the true case.
In summary, this paper presents initial evidence that non-invasive tomography of tumors with
PpIX fluorescence can be achieved, using non-contact near-infrared signal measurement. The
most important factor in being able to achieve this imaging was the use of single photon
counting, which allowed imaging through deep tissue in a reasonable timeframe. Another
important factor was the use of ratio data of the fluorescence to transmission signals, acquired
simultaneously, because this ratio is resistant to many calibration errors, distance inaccuracies
or tissue heterogeneity. The exterior boundary from microCT provided higher accuracy in
localization of the reconstructed volume, and so the combination of microCT and fluorescence
tomography was beneficial. Further use of interior structures from microCT imaging could
also enhance the localization and quantitative estimation of fluorescence in vivo.
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Figure 1.
The fluorescence tomography system photograph is shown in (a), with the main components
labeled. A tomography dataset as measured through a tissue phantom, and (b) the reconstructed
image data is overlayed on this, and in (c) the recovered image from the phantom is shown.
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Figure 2.
The reconstructed quantum yield multiplied by the fluorophore absorption coefficient is shown
within the region of the phantom, for a range of increasing PpIX concentrations. The linearity
of the recovery provides a reliable way to calibrate the concentration from within tomographic
images.
Kepshire et al. Page 6
J Biomed Opt. Author manuscript; available in PMC 2010 May 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 3.
Image of the rodent glioma tumor, as viewed by contrast magnetic resonance imaging (a), and
the fluorescence tomography image of PpIX in (b), and the overlay of this image onto the
MicroCT image of the cranium slice (c).
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